[GENM] QoQ TTM Result on 30-Jun-2005 [#2]

Stock
[GENM] GENTING MALAYSIA BERHAD
Announcement Date
26-Aug-2005
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2005
Quarter
30-Jun-2005 [#2]
Profit Trend
QoQ- 18.37%
YoY- 39.92%
Quarter Report
Latest QR
Upcoming QR
GENM's Result
GENM's Financial Summary
View:
Show?
TTM Result
31/03/06 31/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 CAGR
Revenue 3,636,532 3,613,980 3,365,962 3,090,774 2,915,822 2,838,938 2,861,811 17.33%
PBT 1,237,528 1,301,575 1,101,904 992,631 855,214 833,881 896,545 23.99%
Tax -227,300 -333,683 -105,389 -61,932 -68,866 -80,527 -279,033 -12.78%
NP 1,010,228 967,892 996,515 930,699 786,348 753,354 617,512 38.88%
-
NP to SH 1,010,609 968,178 996,706 930,794 786,348 753,354 617,512 38.91%
-
Tax Rate 18.37% 25.64% 9.56% 6.24% 8.05% 9.66% 31.12% -
Total Cost 2,626,304 2,646,088 2,369,447 2,160,075 2,129,474 2,085,584 2,244,299 11.05%
-
Net Worth 5,459,193 5,580,818 5,416,623 5,208,154 4,979,812 4,749,375 4,552,089 12.89%
Dividend
31/03/06 31/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 CAGR
Div 262,084 262,084 229,284 229,284 218,369 218,369 201,956 18.99%
Div Payout % 25.93% 27.07% 23.00% 24.63% 27.77% 28.99% 32.70% -
Equity
31/03/06 31/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 CAGR
Net Worth 5,459,193 5,580,818 5,416,623 5,208,154 4,979,812 4,749,375 4,552,089 12.89%
NOSH 1,091,838 1,092,136 1,092,061 1,091,856 1,092,064 1,091,810 1,091,628 0.01%
Ratio Analysis
31/03/06 31/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 CAGR
NP Margin 27.78% 26.78% 29.61% 30.11% 26.97% 26.54% 21.58% -
ROE 18.51% 17.35% 18.40% 17.87% 15.79% 15.86% 13.57% -
Per Share
31/03/06 31/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 CAGR
RPS 333.06 330.91 308.22 283.08 267.00 260.02 262.16 17.31%
EPS 92.56 88.65 91.27 85.25 72.01 69.00 56.57 38.89%
DPS 24.00 24.00 21.00 21.00 20.00 20.00 18.50 18.96%
NAPS 5.00 5.11 4.96 4.77 4.56 4.35 4.17 12.87%
Adjusted Per Share Value based on latest NOSH - 1,091,856
31/03/06 31/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 CAGR
RPS 64.15 63.75 59.38 54.52 51.44 50.08 50.48 17.34%
EPS 17.83 17.08 17.58 16.42 13.87 13.29 10.89 38.95%
DPS 4.62 4.62 4.04 4.04 3.85 3.85 3.56 18.99%
NAPS 0.963 0.9845 0.9555 0.9187 0.8784 0.8378 0.803 12.88%
Price Multiplier on Financial Quarter End Date
31/03/06 31/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 CAGR
Date 31/03/06 30/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 -
Price 2.64 2.24 2.20 1.90 1.87 2.00 2.00 -
P/RPS 0.79 0.68 0.71 0.67 0.70 0.77 0.76 2.61%
P/EPS 2.85 2.53 2.41 2.23 2.60 2.90 3.54 -13.46%
EY 35.06 39.58 41.49 44.87 38.51 34.50 28.28 15.41%
DY 9.09 10.71 9.55 11.05 10.70 10.00 9.25 -1.15%
P/NAPS 0.53 0.44 0.44 0.40 0.41 0.46 0.48 6.83%
Price Multiplier on Announcement Date
31/03/06 31/12/05 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 CAGR
Date 31/05/06 22/02/06 25/11/05 26/08/05 27/05/05 25/02/05 30/11/04 -
Price 2.44 2.52 2.12 2.02 1.90 2.10 1.93 -
P/RPS 0.73 0.76 0.69 0.71 0.71 0.81 0.74 -0.90%
P/EPS 2.64 2.84 2.32 2.37 2.64 3.04 3.41 -15.69%
EY 37.93 35.18 43.05 42.20 37.90 32.86 29.31 18.77%
DY 9.84 9.52 9.91 10.40 10.53 9.52 9.59 1.73%
P/NAPS 0.49 0.49 0.43 0.42 0.42 0.48 0.46 4.30%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment